中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2014年
2期
29-31
,共3页
剖宫产%再次妊娠%阴道分娩
剖宮產%再次妊娠%陰道分娩
부궁산%재차임신%음도분면
Cesarean section%Pregnancy again%Vaginal delivery
目的 探讨剖宫产术后再次妊娠阴道分娩对母婴结局的影响.方法 选取52例剖宫产术后再次妊娠经阴道分娩的患者为观察对象,随机选取同期58例经阴道分娩的初产妇为对照组,对比分析两组产妇阴道试产成功率、不同产程时间、新生儿阿氏评分、产妇出血量以及住院时间.结果 观察组阴道分娩试产成功率为57.69％,对照组为87.93％,两组比较差异无统计学意义(P＞0.05).两组产妇产程所需时间、出血量、新生儿阿氏评分以及住院时间比较差异无统计学意义(P＞0.05).结论 瘢痕子宫不能作为剖宫产术的手术指征,对于符合阴道分娩的产妇应给予阴道试产的计划,提高瘢痕子宫患者自然分娩率.
目的 探討剖宮產術後再次妊娠陰道分娩對母嬰結跼的影響.方法 選取52例剖宮產術後再次妊娠經陰道分娩的患者為觀察對象,隨機選取同期58例經陰道分娩的初產婦為對照組,對比分析兩組產婦陰道試產成功率、不同產程時間、新生兒阿氏評分、產婦齣血量以及住院時間.結果 觀察組陰道分娩試產成功率為57.69％,對照組為87.93％,兩組比較差異無統計學意義(P＞0.05).兩組產婦產程所需時間、齣血量、新生兒阿氏評分以及住院時間比較差異無統計學意義(P＞0.05).結論 瘢痕子宮不能作為剖宮產術的手術指徵,對于符閤陰道分娩的產婦應給予陰道試產的計劃,提高瘢痕子宮患者自然分娩率.
목적 탐토부궁산술후재차임신음도분면대모영결국적영향.방법 선취52례부궁산술후재차임신경음도분면적환자위관찰대상,수궤선취동기58례경음도분면적초산부위대조조,대비분석량조산부음도시산성공솔、불동산정시간、신생인아씨평분、산부출혈량이급주원시간.결과 관찰조음도분면시산성공솔위57.69％,대조조위87.93％,량조비교차이무통계학의의(P＞0.05).량조산부산정소수시간、출혈량、신생인아씨평분이급주원시간비교차이무통계학의의(P＞0.05).결론 반흔자궁불능작위부궁산술적수술지정,대우부합음도분면적산부응급여음도시산적계화,제고반흔자궁환자자연분면솔.
Objective To investigate the feasibility of vaginal delivery in cesarean section pregnancy again.Methods Fifty-two patients with cesarean subsequent pregnancy vaginal delivery were selected as observation subjects and 58 cases of vaginal delivery primipara were selected as control group at the same time.The maternal vaginal trial production success rate,different time of the birth process,neonatal Apgar score,amount of bleeding in patients,and hospital stay was analyzed.Results The success rate of vaginal childbirth trial production was 57.69％ in observation group,and the success rate of vaginal delivery trial production in the control group was 87.93 ％,there was no significant difference between the two groups(P ＞ 0.05).There were no significant differences in the maternal labor time,the amount of bleeding,neonatal Apgar score,and length of hospital stay between the two groups (P ＞ 0.05).Conclusions Uterine scar can not be used as indications for cesarean section surgery,patients with the vaginal delivery indications should be given the opportunities of vaginal trial production,to improve the rate of natural childbirth in patients with uterine scar.
